133 related articles for article (PubMed ID: 16670944)
1. A case of relapsing glioblastoma multiforme responding to vinorelbine.
Biassoni V; Casanova M; Spreafico F; Gandola L; Massimino M
J Neurooncol; 2006 Nov; 80(2):195-201. PubMed ID: 16670944
[TBL] [Abstract][Full Text] [Related]
2. Ganglioglioma occurring with glioblastoma multiforme: separate lesions or the same lesion?
Stevens QE; Howes G; Dickerman RD; Lee JM; Nardone EM
Clin Neurol Neurosurg; 2007 Feb; 109(2):195-9. PubMed ID: 17056178
[TBL] [Abstract][Full Text] [Related]
3. Pseudoprogression and treatment effect.
Jahangiri A; Aghi MK
Neurosurg Clin N Am; 2012 Apr; 23(2):277-87, viii-ix. PubMed ID: 22440871
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors.
Hanley ML; Elion GB; Colvin OM; Modrich PL; Keir S; Adams DJ; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1998; 42(6):479-82. PubMed ID: 9788574
[TBL] [Abstract][Full Text] [Related]
5. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.
Brada M; Hoang-Xuan K; Rampling R; Dietrich PY; Dirix LY; Macdonald D; Heimans JJ; Zonnenberg BA; Bravo-Marques JM; Henriksson R; Stupp R; Yue N; Bruner J; Dugan M; Rao S; Zaknoen S
Ann Oncol; 2001 Feb; 12(2):259-66. PubMed ID: 11300335
[TBL] [Abstract][Full Text] [Related]
6. Single agent vinorelbine in pediatric patients with progressive optic pathway glioma.
Cappellano AM; Petrilli AS; da Silva NS; Silva FA; Paiva PM; Cavalheiro S; Bouffet E
J Neurooncol; 2015 Jan; 121(2):405-12. PubMed ID: 25366366
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
8. Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.
Kuttesch JF; Krailo MD; Madden T; Johansen M; Bleyer A;
Pediatr Blood Cancer; 2009 Oct; 53(4):590-3. PubMed ID: 19533657
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
10. Diffuse intrinsic brainstem tumor in an infant: a case of therapeutic efficacy with vinorelbine.
Cappellano AM; Bouffet E; Cavalheiro S; Seixas MT; da Silva NS
J Pediatr Hematol Oncol; 2011 Mar; 33(2):116-8. PubMed ID: 21228720
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
[TBL] [Abstract][Full Text] [Related]
12. Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.
Cortés J; Dieras V; Ro J; Barriere J; Bachelot T; Hurvitz S; Le Rhun E; Espié M; Kim SB; Schneeweiss A; Sohn JH; Nabholtz JM; Kellokumpu-Lehtinen PL; Taguchi J; Piacentini F; Ciruelos E; Bono P; Ould-Kaci M; Roux F; Joensuu H
Lancet Oncol; 2015 Dec; 16(16):1700-10. PubMed ID: 26596672
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for malignant gliomas.
Marosi C
Wien Med Wochenschr; 2006 Jun; 156(11-12):346-50. PubMed ID: 16944366
[TBL] [Abstract][Full Text] [Related]
14. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
Massimino M; Biassoni V; Miceli R; Schiavello E; Warmuth-Metz M; Modena P; Casanova M; Pecori E; Giangaspero F; Antonelli M; Buttarelli FR; Potepan P; Pollo B; Nunziata R; Spreafico F; Podda M; Anichini A; Clerici CA; Sardi I; De Cecco L; Bode U; Bach F; Gandola L
J Neurooncol; 2014 Jun; 118(2):305-312. PubMed ID: 24696052
[TBL] [Abstract][Full Text] [Related]
15. Transitory, spontaneously recovering, peripheral facial nerve palsy after vionorelbine administration.
Cherif J; M'hamdi S; Osman M; Mehiri N; Zouaoui A; Zouheir S; Louzir B; Béji M
Tunis Med; 2010 Jul; 88(7):513-6. PubMed ID: 20582890
[TBL] [Abstract][Full Text] [Related]
16. Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
Deininger MH; Grote E; Wickboldt J; Meyermann R
J Neurooncol; 2000 Jun; 48(2):121-9. PubMed ID: 11083075
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
Galanis E; Buckner JC; Maurer MJ; Kreisberg JI; Ballman K; Boni J; Peralba JM; Jenkins RB; Dakhil SR; Morton RF; Jaeckle KA; Scheithauer BW; Dancey J; Hidalgo M; Walsh DJ;
J Clin Oncol; 2005 Aug; 23(23):5294-304. PubMed ID: 15998902
[TBL] [Abstract][Full Text] [Related]
19. [Pattern of care of high-grade gliomas].
Laigle-Donadey F; Sanson M
Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
[TBL] [Abstract][Full Text] [Related]
20. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
